Home
>
National Drug Code (NDC)
>
Labetalol hydrochloride
Labetalol hydrochloride - 0591-0607-10 - (Labetalol hydrochloride)
Drug Information of Labetalol hydrochloride
| Product NDC: | 0591-0607 |
| Proprietary Name: | Labetalol hydrochloride |
| Non Proprietary Name: | Labetalol hydrochloride |
| Active Ingredient(s): | 300 mg/1 & nbsp; Labetalol hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Labetalol hydrochloride
| Product NDC: | 0591-0607 |
| Labeler Name: | Watson Laboratories, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA075133 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19980803 |
Package Information of Labetalol hydrochloride
| Package NDC: | 0591-0607-10 |
| Package Description: | 1000 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0591-0607-10) |
NDC Information of Labetalol hydrochloride
| NDC Code | 0591-0607-10 |
| Proprietary Name | Labetalol hydrochloride |
| Package Description | 1000 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0591-0607-10) |
| Product NDC | 0591-0607 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Labetalol hydrochloride |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 19980803 |
| Marketing Category Name | ANDA |
| Labeler Name | Watson Laboratories, Inc. |
| Substance Name | LABETALOL HYDROCHLORIDE |
| Strength Number | 300 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] |
